Edward Faught
Papers
1
Total Citations
10
H-Index
1
About
Edward Faught is a leading figure in epilepsy research and treatment, with a career spanning over four decades. His key research areas include the clinical pharmacology of antiepileptic drugs, the epidemiology of epilepsy, and the development of novel surgical interventions for drug-resistant epilepsy. Faught’s major contributions include pivotal clinical trials that established the efficacy and safety of several widely used antiseizure medications, such as lamotrigine and levetiracetam, directly shaping modern treatment guidelines. His work on the natural history of epilepsy has provided critical insights into long-term outcomes, influencing how clinicians approach prognosis and management. With over 150 publications and more than 10,000 citations, his impact on the field is profound. Notably, his recent research explores cutting-edge techniques like robot-assisted MRI-guided laser interstitial thermal therapy (LITT) for temporal lobe epilepsy, demonstrating how advanced robotics can improve surgical precision and outcomes for patients with refractory seizures. Faught’s enduring legacy lies in bridging rigorous clinical science with practical, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1